ES410933A1 - Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles. - Google Patents

Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles.

Info

Publication number
ES410933A1
ES410933A1 ES410933A ES410933A ES410933A1 ES 410933 A1 ES410933 A1 ES 410933A1 ES 410933 A ES410933 A ES 410933A ES 410933 A ES410933 A ES 410933A ES 410933 A1 ES410933 A1 ES 410933A1
Authority
ES
Spain
Prior art keywords
methylene
hydrogen
estren
general formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES410933A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES410933A1 publication Critical patent/ES410933A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES410933A 1972-02-11 1973-01-24 Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles. Expired ES410933A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES410933A1 true ES410933A1 (es) 1976-03-01

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
ES410933A Expired ES410933A1 (es) 1972-02-11 1973-01-24 Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles.

Country Status (29)

Country Link
JP (1) JPS5829317B2 (fi)
KR (1) KR780000156B1 (fi)
AT (1) AT327413B (fi)
AU (1) AU467306B2 (fi)
BE (1) BE795241A (fi)
CA (1) CA997753A (fi)
CH (2) CH593995A5 (fi)
CS (1) CS193019B2 (fi)
DD (1) DD102379A5 (fi)
DE (1) DE2207421C3 (fi)
DK (1) DK131037B (fi)
EG (1) EG10914A (fi)
ES (1) ES410933A1 (fi)
FI (1) FI52225C (fi)
FR (1) FR2181719B1 (fi)
GB (1) GB1425636A (fi)
GR (1) GR63160B (fi)
HU (1) HU165253B (fi)
IE (1) IE37266B1 (fi)
IL (1) IL41506A (fi)
NL (1) NL177217C (fi)
NO (2) NO140304C (fi)
PH (1) PH9370A (fi)
PL (1) PL81084B1 (fi)
RO (1) RO73527A (fi)
SE (3) SE403781B (fi)
SU (1) SU513628A3 (fi)
YU (1) YU35035B (fi)
ZA (1) ZA73944B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
CH590883A5 (fi) 1977-08-31
YU24373A (en) 1979-12-31
KR780000156B1 (en) 1978-05-02
AU5207673A (en) 1974-08-15
IE37266L (en) 1973-08-11
RO73527A (ro) 1982-02-01
EG10914A (en) 1976-09-30
SE409329B (sv) 1979-08-13
GR63160B (en) 1979-09-25
NO143065B (no) 1980-09-01
SE7514513L (sv) 1975-12-22
DD102379A5 (fi) 1973-12-12
SE7713896L (sv) 1977-12-07
YU35035B (en) 1980-06-30
AT327413B (de) 1976-01-26
CH593995A5 (fi) 1977-12-30
CA997753A (en) 1976-09-28
AU467306B2 (en) 1975-11-27
DK131037C (fi) 1975-10-20
ZA73944B (en) 1973-11-28
NO143065C (no) 1980-12-10
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
ATA112473A (de) 1975-04-15
IL41506A0 (en) 1973-04-30
IE37266B1 (en) 1977-06-08
DK131037B (da) 1975-05-20
PL81084B1 (fi) 1975-08-30
NL7301974A (fi) 1973-08-14
NO140304B (no) 1979-04-30
JPS5829317B2 (ja) 1983-06-22
DE2207421A1 (de) 1973-08-16
SE426834B (sv) 1983-02-14
CS193019B2 (en) 1979-09-17
NO782754L (no) 1973-08-14
NL177217B (nl) 1985-03-18
FR2181719B1 (fi) 1975-11-21
DE2207421B2 (de) 1980-07-24
FI52225B (fi) 1977-03-31
IL41506A (en) 1976-07-30
HU165253B (fi) 1974-07-27
GB1425636A (en) 1976-02-18
PH9370A (en) 1975-10-22
NL177217C (nl) 1985-08-16
FR2181719A1 (fi) 1973-12-07
SU513628A3 (ru) 1976-05-05
DE2207421C3 (de) 1981-05-07
BE795241A (fr) 1973-08-09
JPS4886856A (fi) 1973-11-15
FI52225C (fi) 1977-07-11

Similar Documents

Publication Publication Date Title
ES401968A1 (es) Procedimiento para la preparacion de perhidrobenzindenos.
ES434304A1 (es) Procedimiento para preparar esteres del acido dihidro-16,17apovincaminico.
ES462662A1 (es) Procedimiento de preparacion del acido (fenil-3-amino-2-pro-pioniloxi)-2-acetico.
ES410933A1 (es) Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles.
ES478128A1 (es) Procedimiento para la obtencion de compuestos esteroides de la serie pregnano.
ES429020A1 (es) Procedimiento para preparar nuevos derivados de tiazol-5- metanol.
ES417164A1 (es) Procedimiento para la preparacion de cardenolid-3,2-desoxi-glicosidos.
ES416879A1 (es) Procedimiento para la preparacion de 2n3-hidroxi-3alfa-ami-no-esteroides.
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES435204A1 (es) Procedimiento para la preparacion de 11beta -fluor-andros- tenos.
ES400056A1 (es) Procedimiento para la preparacion de nuevos 16 alfa, 16 al-fa-metilenesteroides.
ES391993A1 (es) Procedimiento para la preparacion de derivados de teofilina
ES383115A1 (es) Procedimiento para la preparacion de cardenolid o bufadie- nolid-3-(2, 3-didesoxiglicosidos).
ES382098A1 (es) Procedimiento para la preparacion de nuevas 14 beta-hidro- xi-15 alfa-aciloxi-cardenolidas.
ES453133A1 (es) Procedimiento para la preparacion de 12-epi-digoxina y sus derivados.
ES376027A1 (es) Un procedimiento para la preparacion de nuevos 3-desoxo-19-nor-esteroides.
ES415653A1 (es) Un procedimiento para la preparacion de derivados antiame- bicos de la benzo (a)-quinolicidina.
ES405195A3 (es) Procedimiento de preparacion de combinaciones tipo acido 3,4, 5-trialcoxibenzoilaminoalcanocarboxilico y sus sales.
ES384331A1 (es) Procedimiento para la obtencion de 6 alfa-metil-19-nor- progesterona.
ES392356A1 (es) Un procedimiento para la preparacion de 17-aza-esteroides basicos y sus sales.
ES447916A1 (es) Procedimiento de preparacion de derivados acetal.
ES393637A1 (es) Procedimiento de preparacion de esteroides.
ES368164A1 (es) Procedimiento para la obtencion de 21- aldehidos de la se- rie pregnano y de sus derivados.
ES265558A1 (es) Procedimiento para la preparacion de derivados de 1-metil-estratieno
ES325366A1 (es) Procedimiento para la produccion de derivados de la isoquinolina.